Understanding how lung cells repair themselves in pulmonary fibrosis
Targeting dysfunctional epithelial repair in pulmonary fibrosis
This study is looking at how lung cells heal after they get hurt, especially for people with Idiopathic Pulmonary Fibrosis (IPF), to find out why some healing processes work well while others don’t, which could help develop better treatments for you.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-10946269 on NIH RePORTER |
What this research studies
This research investigates the mechanisms behind how lung epithelial cells repair themselves after injury, particularly in the context of Idiopathic Pulmonary Fibrosis (IPF). It focuses on identifying the differences between effective and ineffective repair processes, using advanced techniques like single-cell RNA sequencing to analyze lung cells from patients. By studying how certain lung cells behave after repeated injuries, the research aims to uncover pathways that lead to dysfunctional repair, which could inform new treatment strategies for patients with pulmonary fibrosis.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Idiopathic Pulmonary Fibrosis or those experiencing chronic lung injury.
Not a fit: Patients with acute lung injuries that do not progress to fibrosis may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapies that improve lung repair and function in patients with pulmonary fibrosis.
How similar studies have performed: Other research has shown promise in understanding lung repair mechanisms, but this specific approach focusing on dysfunctional epithelial repair in pulmonary fibrosis is relatively novel.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Blackwell, Timothy S. — University of Michigan at Ann Arbor
- Study coordinator: Blackwell, Timothy S.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.